Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Jhanelle Gray

Dr. Jhanelle Gray

Chair, Department of Thoracic Oncology

Dr. Jhanelle Gray is a noted medical oncologist and chair of the Department of Thoracic Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa.

Get in touch
Jump to a Topic:

About Jhanelle Gray

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Board Certified icon

    Board Certified in Medical Oncology

  • Board Certified icon

    Board Certified in Thoracic Surgery

Get to Know Dr. Jhanelle Gray

Dr. Jhanelle Gray treats patients with pleural mesothelioma and other thoracic malignancies as part of a multidisciplinary program at the H. Lee Moffitt Cancer Center.

Her research focus today is evaluating new molecular targets and biomarkers in lung cancer to better personalize treatment and reduce chemotherapy resistance, which has been a particular problem with mesothelioma.

As part of the research team, Gray works closely with thoracic surgeon Dr. Jacques Fontaine, head of the mesothelioma program at Moffitt, along with radiologists, pathologists and epidemiologists in the Department of Thoracic Oncology.

She has played a major role in Moffitt’s leadership as a cancer center, turning translational research into novel clinical advances that improve quality of life and outcomes for patients going through mesothelioma treatment.

Gray began practicing medicine in 2007. She serves as principal investigator of several clinical trials involving lung cancer.

Specialties of Dr. Jhanelle Gray

Dr. Jhanelle Gray’s Experience and Medical Education

  • H. Lee Moffitt Cancer Center

  • H. Lee Moffitt Cancer Center & Research Institute (Fellowship)

  • New York Presbyterian Hospital (Residency)

  • Weill Medical College of Cornell University (M.D.)

Dr. Jhanelle Gray’s Awards and Certifications

  • Board certified in medical oncology

  • Board certified in hematology

  • Healthgrades Honor Roll

See More Top Mesothelioma Doctors

Publications of Dr. Jhanelle Gray

  • Perez, B.A. et al. (2020, September 28). A Prospective Single Arm Phase I/II Study: Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics.

  • Gray, J.E. et al. (2020, February 15). Three-Year Overall Survival with Durvalumab after Chemotherapy in Stage III NSCLC — Update from PACIFIC. Journal of Thoracic Oncology.

  • Gray, J.E. et al. (2019, November 25). Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer. Clinical Cancer Research.

  • Gray, J.E. et al. (2019, November 15). Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research.

Disclaimer: Dr. Jhanelle Gray has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Moffitt Cancer Center. (n.d.). Jhanelle Gray, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 15, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now